Parkinson's and Dementia: What Families Need to Know About Clinical Trials

There are plenty of things families worry about when someone they love has Parkinson's, cognitive decline is often the one nobody wants to say out loud. The tremor is visible. The stiffness is visible. But the idea that memory and thinking might change over time sits in the background, unaddressed, because it feels too heavy to bring into the room.

What the Research Actually Shows

Cognitive changes are a recognized part of Parkinson's for many people, though not for everyone and not on a predictable timeline. Mild cognitive impairment is relatively common and does not necessarily progress to dementia. Parkinson's disease dementia develops in a meaningful portion of people over time, but a diagnosis of Parkinson's is not a diagnosis of dementia. Many people live for decades with little to no cognitive change.

Why Cognitive Symptoms Are Hard to Study

Cognitive changes are harder to measure cleanly than motor symptoms. A tremor is observable. A change in how someone processes information is more subjective and influenced by sleep, mood, and medication. Many cognitive trials are observational, tracking participants over time to understand how changes develop and what predicts them.

What Trials Are Studying Right Now

Understanding Who Is at Risk

Observational trials are tracking participants over years to identify early signs that predict cognitive decline, including REM sleep behavior disorder and gait problems.

Targeting Inflammation

Brain inflammation plays a role in cognitive decline in Parkinson's. Several trials are testing whether reducing inflammation can slow or prevent cognitive deterioration.

Targeting Cognitive Decline Directly

A Phase 2 trial is testing whether citalopram, already FDA-approved for depression, can reduce amyloid plaque buildup in brain regions associated with cognitive decline in Parkinson's.

Supporting Caregivers

The PERSEVERE study is testing an educational program for family caregivers of people with Parkinson's disease dementia. All participation is virtual.

Who Can Participate

Some trials recruit people who already have cognitive impairment. Others recruit people with Parkinson's who have no cognitive symptoms yet. Several studies are specifically designed for caregivers, not patients.

The Conversation Worth Having

If cognitive changes are something your family is noticing or worried about, raise it with your neurologist. They can assess where things stand and tell you which trials might be relevant.